MARTIN MACKAY

CIK 1414815 · Executive Chairman · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.53M

Companies

6

Total Filings

89

Lifetime Open-Market Net

$103.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRL Director 15,730 $187.51 $2.95M $0 13 2026-05-11
KLRA Director $0 1 2026-04-20
RLYB Executive Chairman 714,630 $15.92 $11.38M $103.5K 7 2026-02-20
SpringWorks Therapeutics, Inc. (SWTX) Delisted Director 0 $46.99 $0 $0 3 2025-07-02
5:01 Acquisition Corp. (FVAM) Delisted Director $10.00 $0 1 2020-10-20
PFE Senior Vice President 389,172 $26.21 $10.20M $0 50 2010-05-18

Recent Filings · Page 4 of 9

89 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-02-08 Mixed +7,892 -$540.7K
2015-08-05 Mixed -$2.88M
2015-05-22 Sell (S) −4,056 -$650.3K
2015-03-03 Mixed +4,730 -$66.7K
2015-02-12 Sell (S) −3,897 -$678.0K
2015-02-09 Grant (A) +11,690 $0
2014-11-04 Mixed -$812.4K
2014-03-04 Grant (A) +3,000 $0
2013-05-15 Grant (A) +25,000 $0
2010-05-18 PFE Grant (A) $0 EDGAR
Showing 3140 of 89
Page 4 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.